Introduction {#s01}
============

T follicular helper (Tfh) cells are a functionally and phenotypically distinct subset of CD4^+^ T helper (Th) cells critical for humoral immunity. Tfh cells reside in B cell follicles and the germinal centers (GCs) of secondary lymphoid organs, therein secreting their canonical cytokine IL-21, which is necessary for GC B cell development and maintenance ([@bib85]). These cells also secrete IFN-γ and IL-4 in type 1 and 2 immune responses, respectively, which are needed for B cell maturation and the Ig isotype switching appropriate to pathogen challenge ([@bib67]; [@bib19]; [@bib49]; [@bib65]; [@bib32]; [@bib71]; [@bib36]; [@bib96]; [@bib90]), along with IL-9, which promotes B cell memory development ([@bib86]). Defects in either Tfh cell development or function or in antibody production can lead to a failure of viral control ([@bib18]; [@bib23]; [@bib66]).

Tfh cell development is initiated in the T cell zone of secondary lymphoid organs when naive T cells are activated by antigen (Ag)-primed dendritic cells in IL-2--limited environments ([@bib3]; [@bib10]; [@bib34]), with IL-6 signaling in nascent Tfh cells leading to signal transducer and activator of transcription (STAT) 3 activation and expression of the canonical Tfh cell transcription factor B cell lymphoma 6 (Bcl6; [@bib11]). Dendritic cells also express inducible co-stimulator (ICOS) ligand, which signals through ICOS on developing Tfh cells to transiently inactivate FOXO1, enabling Bcl6-mediated transcriptional regulation ([@bib58]; [@bib80]; [@bib87]). The latter represses the transcription factors T box--containing protein expressed in T cells (T-bet) and GATA3, inhibiting differentiation toward Th1 and Th2 pathways, respectively ([@bib94]), while driving the Tfh cell differentiation program ([@bib27]; [@bib59]; [@bib94]), a program also promoted by the transcription factor Ascl2 ([@bib38]).

Bcl6 and Ascl2 regulate expression of surface proteins on Tfh cells, including the chemokine receptor CXCR5, necessary for their migration into the B cell follicle ([@bib73]); ICOS, needed for their survival, follicular migration, and support of B cell maturation ([@bib14]; [@bib48]; [@bib45]; [@bib91]; [@bib37]); and programmed death 1 (PD-1), needed for their GC regulation with the consequent promotion of B cell selection ([@bib20]).

A separate subset of CD4^+^ Th cells, Th1 cells, is critical for protection against challenges by intracellular pathogens ([@bib53]). Th1 cells require the expression of the transcription factor T-bet for their development ([@bib81]). T-bet is up-regulated in CD4^+^ Th cells upon signaling via the TCR and the IFN-γ receptor, with subsequent engagement and phosphorylation of STAT1 ([@bib54]; [@bib1]; [@bib95]). IL-12 signaling via STAT4 further stabilizes T-bet and the Th1 cell phenotype ([@bib54]; [@bib83]; [@bib77]; [@bib95]). T-bet thereupon initiates transcription of the canonical Th1 cell cytokine *Ifng* and silences the expression of the Th2 cytokine *Il4* ([@bib13]). Subsequent IFN-γ signaling cements Th1 differentiation via increased STAT1-mediated gene transcription, which, in concert with IL-12--driven STAT4 signaling, perpetuates *Tbx21* (gene encoding T-bet) and *Ifng* expression ([@bib35]; [@bib83]; [@bib88]; [@bib95]).

Although Tfh and Th1 cells are phenotypically and functionally distinct, they share a transitional developmental stage after T cell activation. In addition to promoting *Tbx21* and *Ifng* expression in Th1 cells, STAT4 drives the expression of *Bcl6* and the canonical Tfh cell cytokine *Il21* in both mouse and human Tfh cells in vitro ([@bib75]; [@bib55]) and binds to and epigenetically regulates *Il21* in polarized Th1 cells ([@bib88]). Yet, continued IL-12--driven STAT4 signaling in vitro extinguishes *Bcl6* and *Il21* expression with the development of repressive chromatin marks, cementing T-bet--driven Th1 cell differentiation at the expense of Tfh cells ([@bib55]). Conversely, if transitional T cells receive signaling via ICOS and IL-6 or TGF-β ([@bib17]; [@bib76]; [@bib47]), Tfh cell differentiation is promoted over that of Th1 cells. The developmental link between Th1 and Tfh cells is not entirely severed with their maturation, however, because the two differentiated subsets do not fully repress the *Bcl6* and *Tbx21* loci, respectively ([@bib41]; [@bib55]). The two populations also share functional features, as both produce the canonical Th1 cell cytokine IFN-γ and the canonical Tfh cell cytokine IL-21 upon immunization with a nominal Ag ([@bib43]; [@bib69]) or after viral infection ([@bib69]; [@bib51]). Moreover, Tfh cells transiently express T-bet and IFN-γ upon Ag immunization or in experimental malaria infection ([@bib43]; Carpio et al., 2015).

Yet, the roles of STAT4 and T-bet in promotion of a functional Tfh cell--driven GC response upon type 1 pathogen challenge remain unclear, as does the transcriptional regulation of IFN-γ in Tfh cells. We hypothesized that both of these transcription factors are required for the development of functional Tfh cells after viral challenge and for the secretion of IL-21 and IFN-γ with the consequent humoral immune response. We found that after acute infection with lymphocytic choriomeningitis virus (LCMV), T-bet was coexpressed with Bcl6 in Tfh cells, with the former transcription factor necessary for their expansion and secretion of IFN-γ and with a correspondingly robust GC output. T-bet expression in Tfh cells was STAT4 dependent, as it is in Th1 cells. Although production of IL-21 was independent of T-bet expression, it was dependent on STAT4 signaling. Thus, Tfh cells, like their Th1 counterparts, cosecrete IL-21 and IFN-γ throughout the course of an acute pathogen-induced type 1 immune response, with each cytokine transcriptionally regulated in a distinct manner to properly promote the humoral immune response.

Results {#s02}
=======

Tfh cells upon acute LCMV infection cosecrete IFN-γ and IL-21 {#s03}
-------------------------------------------------------------

Upon type 1 immune challenge, Tfh cells cosecrete IFN-γ and IL-21; however, the kinetics and mechanism of cytokine cosecretion are not completely understood. To explore these in a system that can be genetically manipulated, we adoptively transferred naive CD4^+^Thy1.1^+^ TCR transgenic T cells specific for the LCMV peptide GP~66-77~ from B6.SMARTA transgenic (Stg) mice into congenically marked Thy1.2^+^ B6 mice, followed by an LCMV Armstrong challenge and a subsequent assessment of the viral-specific splenic T cell response at days 5, 8, 10, and 15 postinfection (p.i.). Viral-specific Th1 cells were gated as CD4^+^Thy1.1^+^CD44^hi^Ly6c^hi^PSGL-1^hi^, and Tfh cells were gated as CD4^+^Thy1.1^+^CD44^hi^Ly6c^lo^PSGL-1^lo^ ([@bib68]; [@bib46]). Down-regulation of PSGL-1 is an early event in Tfh cell differentiation that follows their initial activation by dendritic cells before subsequent B cell contact and, hence, is a marker for these cells ([@bib61]; [@bib68]; [@bib21]; [@bib89]). Th1 cells expanded by day 5 p.i., with the percentage declining at day 8, whereas Tfh cells continued to expand at this time point, remaining stable until day 15 ([Fig. 1 A](#fig1){ref-type="fig"}). The Tfh cell population, gated as CD4^+^Thy1.1^+^CD44^hi^Ly6c^lo^PSGL-1^lo^CXCR5^hi^PD-1^hi^ ([@bib12]; [@bib33]), also peaked at days 8 and 10 before declining at day 15 (p.i.; [Fig. 1 B](#fig1){ref-type="fig"}). For the remainder of our studies, we focused solely on the characterization of this population, gated as CD4^+^Thy1.1^+^CD44^hi^Ly6c^lo^PSGL-1^lo^CXCR5^hi^PD-1^hi^ (designated as Tfh cells in the text), in comparison with Th1 cells, gated as CD4^+^Thy1.1^+^CD44^hi^Ly6c^hi^PSGL-1^hi^.

![**Temporal production of IFN-γ and IL-21 by Tfh and Th1 cells after acute LCMV infection.** Thy1.1^+^ SMARTA TCR transgenic (Stg) CD4^+^ T cells were transferred into Thy1.2^+^ B6 mice, followed by LCMV Armstrong infection 24 h later. Spleens were harvested at days 5, 8, 10, and 15 p.i. Representative flow cytometry plots of splenic Th1 and Tfh cells, with bar graph summaries, are shown. **(A)** PSGL-1^hi^Ly6C^hi^ Th1 cells or PSGL-1^lo^Ly6C^lo^ Tfh cells with percentages of Th1 and Tfh cells. **(B)** CXCR5 and PD-1 gated PSGL-1^lo^Ly6C^lo^ Tfh cells with cell percentages; gates based on CXCR5 and PD-1 staining of Th1 cells. **(C)** Representative flow cytometry plots of intracellular IL-21 and IFN-γ staining of Th1 and Tfh cells with percentages and numbers of cytokine-positive cells. Data are representative of three experiments with three to five recipients per group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig1){#fig1}

Using an unstimulated control as a baseline, we observed three populations of cytokine-secreting Th1 and Tfh cells during infection (IL-21^+^IFN-γ^−^, IL-21^+^IFN-γ^+^, and IL-21^−^IFN-γ^+^; [Fig. 1 C](#fig1){ref-type="fig"}). A majority of the cytokine-producing Th1 cells and Tfh cells coproduced IL-21 and IFN-γ or IFN-γ alone, with only a small percentage of single IL-21 producers. These observations were not specific to TCR transgenic T cells, as the endogenous Thy1.2^+^ Tfh cell population displayed similar kinetics to IL-21 and IFN-γ production (Fig. S1 A). Although the percentage of cytokine double-positive Th1 cells was maintained during the course of infection, their numbers declined alongside a more drastic decrease in the number and percentage of cytokine double-positive Tfh cells ([Fig. 1 C](#fig1){ref-type="fig"}). Thus, a majority of the cytokine-expressing Th1 and Tfh cells coproduced IL-21 and IFN-γ during acute LCMV infection, with a decline in numbers of both populations during the later phase of the GC response.

Temporal expression of Bcl6 and T-bet in Th1 and Tfh cells {#s04}
----------------------------------------------------------

IFN-γ synthesis in Th1 cells is driven by the expression of T-bet ([@bib13]), with T-bet and Bcl6 being coexpressed during the initial differentiation of Th1 cells polarized in vitro ([@bib55]). To test whether T-bet and Bcl6 are also coexpressed during Th1 and Tfh cell differentiation in vivo, we again transferred congenically marked naive Stg CD4^+^ T cells into B6 mice and infected them with LCMV Armstrong, with the expression of the two transcription factors determined in splenic CD4^+^Thy1.1^+^CD44^hi^Ly6c^hi^PSGL-1^hi^ Th1 cells and CD4^+^Thy1.1^+^CD44^hi^Ly6c^lo^PSGL-1^lo^CXCR5^hi^PD-1^hi^ Tfh cells at days 5, 8, 10, and 15 p.i. A significant portion of Th1 cells expressed T-bet on day 5 p.i., with a few cells expressing Bcl6 ([Fig. 2 A](#fig2){ref-type="fig"}, top). In contrast, the majority of Tfh cells at day 5 p.i. expressed both Bcl6 and T-bet, with a minority expressing T-bet alone ([Fig. 2 A](#fig2){ref-type="fig"}, bottom). T-bet expression peaked at day 8 p.i. in Th1 cells, gradually declining by day 15. T-bet expression also decreased in Tfh cells by day 10 p.i, with the remaining transcription factor--positive Tfh cells expressing Bcl6. These observations were not specific to TCR transgenic T cells, as the endogenous Tfh cell population had similar kinetics to transcription factor expression (Fig. S1 B).

![**Expression of T-bet and Bcl6 in Tfh and Th1 cells after acute LCMV infection.** Thy1.1^+^ Stg CD4^+^ T cells were transferred into Thy1.2^+^ B6 mice followed by LCMV Armstrong infection 24 h later. Spleens were harvested at days 5, 8, 10, and 15 p.i. **(A)** Representative flow cytometry plots of intracellular Bcl6 and T-bet in splenic Ly6C^hi^PSGL-1^hi^CXCR5^lo^ Th1 and Ly6c^lo^PSGL-1^lo^CXCR5^hi^PD-1^hi^ Tfh cells, with bar graphs that summarize percentages of transcription factor--expressing cells at each time point p.i. **(B)** Bar graphs that summarize the quantified geometric mean fluorescence intensity (gMFI) of staining of T-bet or Bcl6 from the IL-21-- and/or IFN-γ--secreting Tfh cells (as identified in [Fig.1 C](#fig1){ref-type="fig"}). **(C)** CXCR3 expression on naive and Tfh cells, with gMFI. Data are representative of two or three experiments with three to five recipients per group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig2){#fig2}

We next assessed T-bet and Bcl6 expression in IL-21-- and IFN-γ--secreting Tfh cells. IL-21^+^IFN-γ^+^ Tfh cells maintained the greatest T-bet and Bcl6 expression compared with IL-21^+^IFN-γ^−^ and IL-21^−^IFN-γ^+^ populations, despite their temporal decline throughout infection ([Fig. 2 B](#fig2){ref-type="fig"}). In contrast, non--cytokine-producing Tfh cells had the least expression of T-bet and Bcl6, indicating that transcription factor expression is associated with cytokine secretion.

To validate the kinetics of T-bet expression in Tfh cells, we assessed staining of the chemokine receptor CXCR3, which is dependent on T-bet transcription ([@bib40]). As for T-bet, CXCR3 was highly expressed at day 5 in Tfh cells, with a reduction by day 8 ([Fig. 2 C](#fig2){ref-type="fig"}). These data are consistent with previous in vitro studies demonstrating that polarized Th1 and Tfh cells share a T-bet and Bcl6 intermediate ([@bib55]) while extending these findings to show that in vivo, mature Tfh cells, but not Th1 cells, robustly express both transcription factors early after viral challenge.

T-bet is required for Tfh cell development {#s05}
------------------------------------------

To determine the role of T-bet in regulation of Tfh cell differentiation, congenically marked T-bet--sufficient (T-bet^+/+^), T-bet--heterozygous (T-bet^+/−^), and T-bet--deficient (T-bet^−/−^) Stg CD4^+^ T cells were transferred into B6 mice before infection with LCMV Armstrong. Splenic Tfh cell development among the donor cells was assessed at day 8 p.i., a time point when T-bet is still expressed in Tfh cells ([Fig. 2 A](#fig2){ref-type="fig"}). T-bet^−/−^ cells in comparison with the other two transferred populations had a significant reduction in the percentage and number of Tfh cells ([Fig. 3 A](#fig3){ref-type="fig"}), with the percentage of donor Stg cells that differentiated into Tfh cells significantly reduced in a T-bet dose--dependent manner ([Fig. 3 B](#fig3){ref-type="fig"}). The reduction in Tfh cells in the absence of T-bet was not a consequence of aberrant Bcl6 expression, which was stable in the T-bet mutant cells compared with T-bet--intact ones ([Fig. 3 C](#fig3){ref-type="fig"}), nor was it caused by alterations in Blimp-1, as we observed minimal *Prdm1* (the gene encoding Blimp-1) expression in sorted Tfh cells from T-bet^+/+^, T-bet^+/−^, and T-bet^−/−^ donors compared with control Th1 cells ([Fig. 3 D](#fig3){ref-type="fig"}). In comparison, inhibition of T-bet expression had no effect on Tfh cell development upon challenge with a type 2 immunogen (Fig. S2, A and B). We did observe that after LCMV challenge, a greater percentage of the double-mutant cells, compared with their intact counterparts, down-regulated PSGL-1 ([Fig. 3 E](#fig3){ref-type="fig"}), an early event in Tfh cell differentiation ([@bib61]; [@bib68]; [@bib89]). These findings in aggregate suggest that although the absence of T-bet enhanced initial T cell differentiation along an initial Tfh cell developmental pathway, its presence is required for proper Tfh cell differentiation after type 1 immune challenge as modeled by acute viral infection.

![**T-bet is necessary for T cell development and their robust IFN-γ expression after LCMV challenge.** T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ Thy1.1^+^ Stg CD4^+^ T cells were transferred to Thy1.2^+^ B6 mice, followed by LCMV Armstrong infection 24 h later. Spleens were harvested 8 d p.i. **(A)** Representative flow cytometry plots of CXCR5 and PD-1 gating on PSGL-1^lo^Ly6C^lo^ Tfh cells with bar graphs that summarize cell percentages, cell numbers, and CXCR5 MFI. **(B)** Percentage of donor cells that differentiated into Tfh cells in transfer recipients. **(C)** Representative intracellular Bcl6 and T-bet expression in PSGL-1^lo^CXCR5^hi^PD-1^hi^ Tfh cells with gMFI for both. **(D)** Quantitative RT-PCR for *Prdm1* expression from sorted Tfh cells and control T-bet^+/+^ Th1 cells. **(E)** Representative flow cytometry plots of T-bet^+/+^, T-bet^+/−^, and T-bet^−/−^ CD4^+^Thy1.1^+^PSGL-1^lo^Ly6C^lo^ splenic Tfh cells from recipients, with a bar graph that summarizes percentages of cells. **(F)** Representative flow cytometry plots of intracellular IL-21 and IFN-γ staining of T-bet^+/+^, T-bet^+/−^, and T-bet^−/−^ cells from recipient spleens, with bar graphs that summarize percentages of cells. (**G)** Representative flow cytometry plots of intracellular IL-21 and IL-2 staining of T-bet^+/+^ and T-bet^−/−^ cells from recipient spleens, with a bar graph that summarizes percentages of cells. Data are representative of three experiments with three to five recipients per group. \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig3){#fig3}

We next asked whether T-bet expression in Tfh cells is required for their IFN-γ production, as in Th1 cells ([@bib81]). Intracellular cytokine staining was performed on donor T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ Stg CD4^+^ splenic Tfh cells at 8 d p.i. T-bet^−/−^ Tfh cells had a significant reduction in the percentage of double-positive IL-21^+^IFN-γ^+^ cells compared with that of T-bet^+/+^ and T-bet^+/−^ Tfh cells, a finding in contrast to the significant increase of single IL-21^+^ producers ([Fig. 3 F](#fig3){ref-type="fig"}). Because Th2 cell development is increased in the absence of T-bet ([@bib84]), we also assessed IL-4 production in donor T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ that became Tfh cells after transfer and viral infection; however, we observed no differences in production of this cytokine (Fig. S2 C). These data indicate that T-bet promotes expansion and IFN-γ production by Tfh cells after viral infection, as in Th1 cells, but that it does not regulate their IL-21 or IL-4 production.

Because T-bet is a negative regulator of IL-2 production, which in turn negatively regulates Bcl-6 and promotes Blimp-1 expression ([@bib63]), we also assessed IL-2 synthesis by Tfh cells, finding enhanced secretion alongside that of IL-21 in the mutant cells ([Fig. 3 G](#fig3){ref-type="fig"}**).** Despite increased IL-2 expression in mutant cells compared with T-bet--intact cells, this did not alter their expression of Bcl6 or *Prdm1* ([Fig. 3, C and D](#fig3){ref-type="fig"}). Thus, while promoting IFN-γ production in Tfh cells during acute viral infection, T-bet inhibits that of IL-2, helping to cement the Tfh cell phenotype ([@bib60]; [@bib39]).

T-bet--intact and T-bet--deficient Tfh cells are transcriptionally distinct {#s06}
---------------------------------------------------------------------------

We next performed a transcriptome analysis of splenic Tfh cells after adoptive transfer of T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ Stg Thy1.1^+^CD4^+^ T cells 8 d p.i. with LCMV Armstrong. We found 837 genes differentially expressed between T-bet^+/−^ and T-bet^+/+^ Tfh cells, with 1,164 genes differentially expressed between the T-bet^+/+^ and T-bet^−/−^ populations ([Fig. 4 A](#fig4){ref-type="fig"}). In the absence of T-bet, 635 genes were up-regulated, including type I IFN--stimulated genes known to be repressed by T-bet in Th1 cells (including *Pyhin1* and *Oasl2*; [@bib26]), with 529 genes down-regulated, including those emblematic of Th1 cell differentiation, including *Ifng* and *Cxcr3* ([Fig. 4 B](#fig4){ref-type="fig"}), as well as *Tbx21.* To further analyze the transcriptional differences among the Tfh cell populations, we examined a curated set of genes previously described to be up- or down-regulated in Tfh cells compared with other CD4^+^ Th subsets ([Fig. 4 C](#fig4){ref-type="fig"}; [@bib4]; [@bib15]; [@bib25]). Although the three Tfh cell populations shared expression of Tfh cell--defining genes including *Bcl6*, *Cxcr5*, and *Sh2d1a* ([Fig. 4 C](#fig4){ref-type="fig"}), as well as reduction in that of *Prdm1* ([Fig. 3 E](#fig3){ref-type="fig"}), the T-bet^−/−^ population had reduced expression of the Tfh cell--associated genes *Irf4* and *Batf.* Pathway enrichment analysis of the down-regulated genes in T-bet^−/−^ compared with T-bet^+/+^ Tfh cells revealed down-regulation of multiple cell cycle pathways and oxidative phosphorylation ([Fig. 4 D](#fig4){ref-type="fig"}), the latter supported by gene set enrichment analysis ([Fig. 4 E](#fig4){ref-type="fig"}). Thus, T-bet has a role in regulating the cytokine, cell division, and metabolic processes of Tfh cells in a manner similar to that in Th1 cells ([@bib26]).

![**T-bet is required for proper transcriptional development of Tfh cells.** T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ Thy1.1^+^ Stg CD4^+^ T cells were transferred into Thy1.2^+^ B6 mice with LCMV Armstrong infection 24 h later. Spleens were harvested 8 d p.i. **(A)** Heat map of significantly differentially expressed genes (rows) in the three populations (columns). FDR, α \< 0.05. **(B)** Volcano plot of gene expression comparing T-bet^+/+^ with T-bet^−/−^ Ly6c^lo^PSGL-1^lo^CXCR5^hi^PD-1^hi^ Tfh cells to identify differentially expressed genes with a cutoff p-value of \<0.05, fold change \>2, comparing T-bet^+/+^ or T-bet^−/−^ cells. **(C)** Heat map of selected T cell--related genes. FDR-adjusted *q* \< 0.05 comparing T-bet^+/+^ or T-bet^−/−^ Tfh cells. Quantitative RT-PCR analysis of selected T cell--related genes, normalized to results obtained for the control gene *Hprt*. Data from two independent sorts using 10 mice each; fragments per kilobase of transcript per million mapped reads (FPKM). **(D)** Enrichment pathways analysis of the down-regulated genes in T-bet^−/−^ Tfh cells, with the top seven pathways listed, including the enrichment p-value and the number of genes per total genes in a pathway. **(E)** Enrichment of gene signatures related to activation of the Kyoto Encyclopedia of Genes and Genomes oxidatve phosphorylation pathway in T-bet^+/+^ versus T-bet^−/−^ Tfh cells. Number in top-right corner is the enrichment score; all p-values and FDRs = 0. \*, P \< 0.05; \*\*, P \< 0.01 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig4){#fig4}

T-bet is required for Tfh cell function {#s07}
---------------------------------------

To evaluate the requirement for T-bet in the Tfh cell function, we transferred naive T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ Stg CD4^+^ T cells into TCR-β^−/−^ mice that lacked T cells; thus, only transferred cells were capable of Tfh cell differentiation and the promotion of a GC response. At day 13 after LCMV infection (the height of the GC response), the reduction in T-bet expression in transferred T cells corresponded with a decrease in the percentage that developed a Tfh phenotype (Fig. S3 A). To account for the Ag-induced expansion defect in T-bet^−/−^ T cells upon adoptive transfer ([@bib46]), we transferred four times as many T-bet^−/−^ as T-bet^+/−^ and T-bet^+/+^ naive CD4^+^ T cells into recipients and found equivalent numbers of Tfh cells among the recipients of the three transferred populations ([Fig. 5 A](#fig5){ref-type="fig"}). Yet, similar to results from transfers into T cell--intact recipients ([Fig. 3 F](#fig3){ref-type="fig"}), T-bet^−/−^ Tfh cells arising from cells transferred into TCR-β^−/−^ mice had defects in IFN-γ production, with reduced numbers of IL-21^+^IFN-γ^+^ double-positive cells compared with T-bet^+/+^ and T-bet^+/−^ donors (Fig. S3 B). In contrast, numbers of IL-21 single-positive cells were equivalent. Despite Tfh cell production of IL-21, and despite equivalent numbers of Tfh cells after transfer, recipients of T-bet^−/−^ cells had a significant reduction of B220^+^IgD^lo^CD95^hi^GL-7^hi^ GC B cells compared with those of T-bet^+/+^ and T-bet^+/−^ recipients ([Fig. 5 B](#fig5){ref-type="fig"}). Ablation of T-bet in Tfh cells also influenced Ig isotype usage, with GC B cells in recipients of T-bet--deficient transfers having increased intracellular IgG1 expression compared with animals receiving T-bet--sufficient CD4^+^ T cells ([Fig. 5 C](#fig5){ref-type="fig"}), consistent with the increase in IgG1 production by GC B cells in IFN-γ^−/−^ mice infected with LCMV (Fig. S3 C). In contrast to the increased IgG1 in recipients of T-bet mutant T cells, intracellular B cell and serum IgG2c was decreased ([Fig. 5, C and D](#fig5){ref-type="fig"}), providing additional evidence that T-bet is required by Tfh cells to ensure the proper maturation of GC B cells appropriate to viral challenge.

![**T-bet in Tfh cells is required for proper GC B cell output after viral infection.** T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ Thy1.1^+^ Stg CD4^+^ T cells were transferred to TCR-β^−/−^ mice. Spleens were harvested 13 d p.i. **(A)** Number of T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ donor cells that differentiated into Tfh cells in spleens of recipients. **(B)** Representative flow cytometry plots of CD4^−^B220^+^IgD^lo^CD95^hi^GL-7^hi^ GC B cells in recipients of T-bet^+/+^, T-bet^+/−^, or T-bet^−/−^ donor cells with cell percentages and numbers. **(C)** Representative flow cytometry plots of intracellular IgG1 and IgG2c staining of GC B cells with percentages of isotype-staining cells. **(D)** Anti-LCMV IgG2c and IgG1 antibodies in sera of recipient mice. **(E)** Splenic B cell follicles of TCR-β^−/−^ recipient mice stained with anti-IgD, anti-CD4, and peanut agglutinin (PNA), with the numbers of T cells per GC size (bottom left) and GC sizes (bottom right) quantified. **(F and G)** Total splenocytes from mice 12 d p.i., co-cultured with CXCL13, CXCL12, or media to assess percentages of Tfh cells migrating to each (F and G) or stained for CXCR4 (G). **(H)** Staining of Tfh cells in recipient spleens for CD40L. Data are representative of three experiments with three to five recipients per group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig5){#fig5}

Even though we observed equivalent numbers of Tfh cells after infection, as assessed by surface phenotype upon transfer ([Fig. 5 A](#fig5){ref-type="fig"}), we wondered whether the reduction in GC output among recipients of the double-mutant population was a consequence of defective GC migration, especially given their reduced expression of CXCR5 ([Fig. 3 A](#fig3){ref-type="fig"} and Fig. S3 A). The number of Tfh cells per GC area was similar to that of recipients of all three populations; however, TCR-β^−/−^ mice infected after receipt of T-bet^−/−^ cells had smaller GCs 13 d p.i. ([Fig. 5 E](#fig5){ref-type="fig"}). Consistent with their reduced CXCR5 expression, T-bet^−/−^ cells migrated less efficiently in vitro to the GC light zone ligand CXCL13 than their T-bet^+/+^ and T-bet^+/−^ counterparts ([Fig. 5 F](#fig5){ref-type="fig"}). In contrast, cell surface expression of the chemokine receptor CXCR4 was increased in T-bet^−/−^ Tfh cells compared with T-bet^+/+^ and T-bet^+/−^ cells, consistent with their increased ability to migrate to the dark zone ligand CXCL12 ([Fig. 5 G](#fig5){ref-type="fig"}; [@bib90]). In addition, surface expression of CD40L ([@bib31]), which via CD40 signaling promotes isotype switching and regulates GC B cell differentiation, was significantly reduced on T-bet^−/−^ Tfh cells compared with T-bet^+/+^ cells ([Fig. 5 H](#fig5){ref-type="fig"}). Thus, even though numbers of T-bet^−/−^ Tfh cells were not substantially different than those of transcription factor--sufficient cells after transfer, their decreased expression of CXCR5 and migration to CXCL13, despite increased expression of CXCR4 and migration to CXCL12, suggested the T-bet^−/−^ cells had defective follicular migration. This, along with a reduction in their expression of IFN-γ and that of CD40L, hindered their ability to promote GC expansion and the isotype switching appropriate to the nature of pathogen challenge. Together, these data indicate that T-bet is required in a dosage-dependent fashion for Tfh expansion, migration, and function, including maximal secretion of IFN-γ and proper GC output after type 1 immune challenge.

STAT4 is necessary for Tfh cell development and cytokine production after acute LCMV infection {#s08}
----------------------------------------------------------------------------------------------

Because Ag-specific T-bet--deficient Tfh cells produced IL-21 equivalent to that of T-bet--intact cells, we next examined the transcriptional regulation of *Il21* by STAT4, given that this factor binds to the *Il21* locus in Th1 cells and its deletion results in ablation of activating histone marks (H3K4me3) within that locus ([@bib88]). STAT4 expression is also shared with that of T-bet in in vitro--polarized Th1 cells that have a Tfh cell intermediate ([@bib55]). We accordingly measured STAT4 phosphorylation (pSTAT4) ex vivo after IL-12 or IFN-β stimulation, both of which are present in viral infections and promote pSTAT4 expression in Th1 cells ([@bib9]; [@bib52]). Naive Stg CD4^+^ T cells were transferred into B6 mice, and splenocytes from days 5, 10, and 15 p.i. were cultured with IL-12 or IFN-β. In response to IL-12 stimulation, Tfh cells taken from recipient mice had significantly increased phosphorylated STAT4 at day 5 compared with those from days 10 and 15 p.i. (Fig. S4 A). pSTAT1 was also increased at day 5 p.i. in response to IL-12 stimulation, consistent with previous studies ([@bib11]), affirming a role for STAT1 phosphorylation in Tfh cell development (Fig. S4 A; [@bib56]). In response to IFN-β stimulation, pSTAT4 was also increased in Tfh cells p.i., with pSTAT1 similarly up-regulated (Fig. S4 B). In contrast, Th1 cells had increased stimulated pSTAT4 to IL-12 and IFN-β at later time points p.i. (Fig. S4 C). In response to IFN-β stimulation, pSTAT1-positive Tfh cells were also pSTAT4 positive (Fig. S4 D), suggesting that signaling by these two STATs is involved in their development. Thus, IL-12 and IFN-β activate STAT4 and STAT1 in Tfh cells early after viral infection, corresponding to the kinetics of their T-bet expression ([Fig. 2 A](#fig2){ref-type="fig"}).

To explore whether pSTAT4 is necessary for Tfh cell differentiation, we transferred congenically marked STAT4^+/+^ or STAT4^−/−^ Stg CD4^+^ T cells into B6 mice and infected them with LCMV. Because pSTAT4 was increased at day 5 p.i in Tfh cells (Fig. S4, A and B), we examined their differentiation in the recipient mice at this time point, finding that donor STAT4^+/+^ and STAT4^−/−^ cells comprised similar percentages of CD4^+^ T cells in recipients, although STAT4^−/−^ cells had reduced expansion ([Fig. 6 A](#fig6){ref-type="fig"}), similar to T-bet^−/−^ donors. Donor T cells were stimulated with IL-12 to reconfirm the presence or absence of pSTAT4 at the time of sacrifice (Fig. S5 A). Th1 cells were decreased in the STAT4^−/−^ donor population compared with those from the STAT4^+/+^ cells ([Fig. 6 B](#fig6){ref-type="fig"}), consistent with the fact that STAT4 is required for Th1 development ([@bib83]). We observed a corresponding increase in the CD4^+^Thy1.1^+^CD44^hi^Ly6c^lo^PSGL-1^lo^ Tfh cell population, similar to that seen with T-bet^−/−^ donors ([Fig. 6 B](#fig6){ref-type="fig"} and [Fig. 3 E](#fig3){ref-type="fig"}). However, unlike T-bet^−/−^ donor cells, the STAT4^−/−^ Ly6c^lo^PSGL-1^lo^ cells did not have a reduced CXCR5 expression ([Fig. 6 C](#fig6){ref-type="fig"}), although the number of Tfh cells was reduced compared with the STAT4^+/+^ donors, presumably a consequence of the expansion defect of the mutants ([Fig. 6 A](#fig6){ref-type="fig"}). Nonetheless, a similar percentage of naive STAT4-deficient and -sufficient donor cells became Tfh cells ([Fig. 6 D](#fig6){ref-type="fig"}). Moreover, the percentage of Bcl6^hi^ Tfh cells and degree of Bcl6 expression among STAT4-deficient donor cells were comparable with those from STAT4-sufficient cells ([Fig. 6 E](#fig6){ref-type="fig"}). STAT4^−/−^ donor cells also produced similar percentages of Tfh cells with equivalent Bcl6 expression compared with STAT4^+/+^ Tfh cells at a later, day 8 p.i. time point (Fig. S5 C).

![**Tfh cells require STAT4 for cytokine production but not formation.** STAT4^+/+^ or STAT4^−/−^ Thy1.1^+^ Stg CD4^+^ T cells were transferred into Thy1.2^+^ B6 mice followed by infection with LCMV Armstrong 24 h later, and spleens were harvested at day 5 p.i. **(A)** Summary of the percentages and numbers of donor CD4^+^ T cells in recipient mice. **(B)** Representative flow cytometry plots of PSGL-1^hi^Ly6C^hi^ Th1 or PSGL-1^lo^Ly6C^lo^ Tfh cells from STAT4^+/+^ or STAT4^−/−^ donors with percentages of cells summarized. **(C)** Representative flow cytometry plots of CXCR5 and PD-1 gating of PSGL-1^lo^Ly6C^lo^ Tfh cells from STAT4^+/+^ and STAT4^−/−^ donors with cell percentages and numbers. **(D)** Percentage of STAT4^+/+^ and STAT4^−/−^ donor CD4^+^ T cells that differentiated into Tfh cells. **(E)** Intracellular and surface staining for Bcl6 and CXCR5, respectively, in CD4^+^Thy1.1^+^Ly6c^lo^PSGL-1^lo^ STAT4^+/+^ and STAT4^−/−^ Tfh cells in recipients of transferred cells with gMFI of Bcl6 staining. **(F)** Intracellular T-bet staining in STAT4^+/+^ and STAT4^−/−^ Thy1.1^+^ PSGL-1^lo^CXCR5^hi^PD-1^hi^ Tfh and in Th1 and naive CD4^+^ T cells with their gMFI. **(G)** Representative flow cytometry plots of intracellular IL-21 and IFN-γ expression in STAT4^+/+^ or STAT4^−/−^ Tfh cells of recipient mice with summary of cell percentages and MFI of staining of Tfh cells. Data are representative of three experiments with five recipients per group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*\*, P \< 0.0001 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig6){#fig6}

We next assessed whether STAT4 regulates T-bet expression in Tfh cells, as it does in Th1 cells ([@bib83]). We found a significant reduction in T-bet expression in the absence of STAT4 in Tfh cells at day 5 p.i. ([Fig. 6 F](#fig6){ref-type="fig"}). This reduction did not affect Bcl6 expression, consistent with our finding that T-bet--deficient Tfh cells also had no such alterations ([Fig. 3 C](#fig3){ref-type="fig"}). T-bet expression in STAT4^−/−^ Tfh cells was not completely ablated and was higher than in naive CD4^+^ T cells, indicating that additional pathways such as STAT1 can separately promote expression of this transcription factor ([@bib1]). Hence, similar to Th1 cells, signaling through STAT4 promotes increased T-bet expression in Tfh cells.

We also asked whether STAT4 is required for Tfh cell production of IL-21, finding that mutant Tfh cells 5 d p.i., compared with STAT4^+/+^ cells, had a reduction in the percentage of IFN-γ^+^ and IL-21^+^IFN-γ^+^ cells, but not IL-21^+^IFN-γ^−^ cells ([Fig. 6 G](#fig6){ref-type="fig"}). Moreover, total IFN-γ and IL-21 expression was decreased in STAT4^−/−^ Tfh cells compared with STAT4^+/+^ cells. Thus, Tfh cells require STAT4 to promote IL-21 and T-bet expression, with the latter driving their IFN-γ production.

We determined whether the reduction in protein expression of transcription factors and cytokines in the absence of STAT4 occurred at the chromatin or transcriptional level. Because STAT4 has been shown to be necessary for IL-12--induced chromatin remodeling of the CD25 locus ([@bib79]), we asked whether it alters the genomic landscape in Tfh cells. We characterized chromatin accessibility via assay for transposase-accessible chromatin using sequencing (ATAC-seq) in STAT4^+/+^ and STAT4^−/−^ Tfh cells at 5 d p.i. Principal component analysis and clustering analyses performed on called peaks revealed that STAT4^+/+^ and STAT4^−/−^ Tfh cells did not form distinct groups (Fig. S5 F). Comparison of differentially called peaks in the two replicates of STAT4^+/+^ versus STAT4^−/−^ cells identified by the DiffBind package with DEseq normalization revealed only 12 differentially expressed peaks from the 35,330 merged regions (false discovery rate \[FDR\] \<0.01). No significant differences were seen in chromatin accessibility at the *Bcl6*, *Il21*, *Tbx21*, and *Ifng* gene loci (Fig. S5 G). A parallel analysis performed to detect differential ATAC peaks using the csaw package yielded similar results ([@bib42]). These findings suggest that the regulation of differential gene expression in STAT4^+/+^ and STAT4^−/−^ Tfh cells is not mediated at the level of chromatin accessibility (Table S3).

We also examined whether these genes were transcriptionally repressed in the absence of STAT4. *Bcl6* expression was similar between STAT4^+/+^ and STAT4^−/−^ Tfh cells, although *Tbx21* expression was significantly reduced in the latter at 5 d p.i. ([Fig. 7 A](#fig7){ref-type="fig"}). *Il21* and *Ifng* expression was significantly reduced in the mutant compared with STAT4^+/+^ cells at 5 d p.i. ([Fig. 7 B](#fig7){ref-type="fig"}). The transcriptional expression of these genes was consistent with the pattern of observed protein expression. Thus, *Bcl6*, *Tbx21*, *Il21*, and *Ifng* expression in Tfh cells is regulated at the transcriptional level and not via changes in chromatin accessibility mediated by STAT4.

![**Influence of STAT4 deletion on gene expression in Tfh cells.** Thy1.2^+^ B6 mice were infected with LCMV a day after receiving in transfer naive Thy1.1^+^STAT4^+/+^ or Thy1.1^+^STAT4^−/−^ Stg CD4^+^ T cells. **(A and B)** Quantitative PCR was performed on sorted splenic Thy1.1^+^PSGL-1^lo^Ly6c^lo^CXCR5^hi^PD-1^hi^ Tfh cells to assess expression of *Tbx21* and *Bcl6* (A) and expression of *Il21* and *Ifng.* (B) Data are representative of two experiments with five recipients per group. \*\*, P \< 0.01; \*\*\*, P \< 0.001 by Student's *t* test. Error bars represent SEM.](JEM_20170457_Fig7){#fig7}

Discussion {#s09}
==========

We found that Tfh and Th1 cells coproduce IFN-γ and IL-21 after acute LCMV infection. Tfh cells required T-bet for IFN-γ secretion and for proliferation, robust CXCR5 expression with proper follicular migration, and CD40L expression---all necessary for GC formation and humoral output. In contrast, IL-21 secretion was not dependent on T-bet but on the presence of STAT4. STAT4 signaling was also necessary for T-bet expression in Tfh cells, as it is in Th1 cells ([@bib83]), and thus is also required for expansion of the former and for GC function upon viral challenge.

Previous studies have examined the divergent roles of T-bet and Bcl6 in the differentiation of Th1 and Tfh cells, largely in in vitro analyses. Initiation of *Tbx21* expression with Th1 cell differentiation in vitro is dependent on IL-12--driven STAT4 signaling, which also promotes *Bcl6* expression ([@bib55]). IL-2R signaling similarly promotes Th1 cell differentiation via expression of Blimp-1 ([@bib55]; [@bib28]; [@bib63]), a repressor of transcription of *Bcl6*; yet, the latter locus in Th1 cells is not fully repressed because T-bet in concert with Bcl6 in Th1 cells is necessary to repress alternative Th cell programs ([@bib55]; [@bib62]). We primarily took an in vivo approach, finding that T-bet--expressing Th1 cells expressed little Bcl6 after viral infection of mice. In contrast, Bcl6-expressing Tfh cells expressed T-bet, which was critical for their development and function and transcriptionally required for proper Tfh cell programming and for pathways of cell cycle and oxidative phosphorylation, as assessed by transcriptome analysis. The finding that T-bet is essential for Tfh cell development is at odds with previous in vitro experiments, in which naive polyclonal T-bet^−/−^ CD4^+^ T cells developed into Tfh cells when transferred into RAG2^−/−^ mice, followed by infection with *Toxoplasma gondii* ([@bib55]). Because naive CD4^+^ T cells and T cells with genetic defects in activation undergo homeostatic proliferation upon transfer into RAG2^−/−^ mice ([@bib50]; [@bib78]), it is possible that naive T-bet^−/−^ cells in these experiments overcame the expansion defect that we have observed ([@bib46]). Likewise, the absence of B cells in RAG-deficient recipients may have contributed to Tfh cell expansion in the toxoplasma infection experiments ([@bib55]), given the role of B cell PD-L1 in regulation of Tfh cell numbers after immune stimulation ([@bib20]). Our experiments also used Ag-specific Tfh cells, which may have additional requirements for expansion in comparison with polyclonal cells analyzed in the earlier transfer into and toxoplasma infection of RAG-deficient recipients.

We found that T-bet and STAT4 expression in Tfh cells was similar to that in Th1 cells, as both transcription factors were expressed early after LCMV infection. Also akin to Th1 cells, *Tbx21* and T-bet expression in Tfh cells was significantly reduced, albeit not ablated, in the absence of STAT4, suggesting that STAT4-independent signaling, likely via STAT1, promotes T-bet expression in Tfh cells, in accordance with its actions in Th1 cells ([@bib1]). Although STAT1 signaling is not known to drive T-bet expression in Tfh cells, it does promote that of Bcl6 ([@bib11]; [@bib56]). Nonetheless, robust Tfh cell expansion was dependent on STAT4 and T-bet. In contrast, *Il21* transcription was dependent on STAT4, and not T-bet, as in Th1 cells ([@bib55]). The dichotomous roles of STAT4 and T-bet in normal Tfh cell function are consistent with the previous observation that subsets of genes depend on the presence of STAT4 or T-bet or of both for their expression in Th1 cells ([@bib83]).

Our finding that STAT4 in Tfh cells did not lead to changes in chromatin configuration is similar to that seen during Th cell development ([@bib93]), in which changes in chromatin configuration distinguishing the induced state in Th1 cells from the repressed state in Th2 cells were STAT4 independent. STAT4 is required for recruitment of the histone acetyltransferase P300 to active enhancers in Th1 cells ([@bib93]). If a similar mechanism is operative in Tfh cells, it is likely that many of the changes in gene expression we observed are driven by differences in histone acetylation, rather than by global rearrangement in chromatin occupancy.

Coordinated secretion of Tfh cell cytokines is necessary for promotion of intact humoral immunity and mediation of host effector function. Mouse IgG2a (or, more precisely, IgG2c in the B6 background used herein) antibodies dependent on Tfh cell T-bet expression and IFN-γ production, as we observed, are protective upon viral infection compared with IgG1 ([@bib74]). The Fc region of secreted IgG2a interacts with complement components and activates critical antiviral Fc receptor--mediated effector functions including the stimulation of antibody-dependent, cell-mediated cytotoxicity and opsonization by macrophages ([@bib29]; [@bib82]). Conversely, in the absence of T-bet, we found that the cytokine production by Tfh cells shifted away from IFN-γ toward IL-21, with enhanced IgG1 anti-LCMV responses. Although well suited for neutralizing secreted proteins produced by invading extracellular pathogens such as helminths, the Fc portion of IgG1 antibodies mediates a lower-affinity interaction with Fc receptors in comparison with IgG2c, with less effective receptor stimulation and consequent inflammatory responses ([@bib24]). Our data also are consistent with recent studies demonstrating that in B cells, IFN-γ, and not IL-21, drives T-bet expression and subsequent IgG2a transcription along with gene expression programs necessary for proliferation and proper B cell localization ([@bib2]; [@bib57]). These findings and ours explain why T-bet expression is required for IFN-γ synthesis by Tfh cells and clearance of experimental malaria infection ([@bib8]), with IFN-γ--driven T-bet expression in GC B cells being necessary for proper isotype switching and function ([@bib2]; [@bib57]), whereas IL-21 is needed for full GC expansion and Ig affinity maturation ([@bib90]).

We show that T-bet and STAT4 are essential for Tfh cell development after acute viral infection and their regulation of IFN-γ and IL-21 production and GC responses. Expression of T-bet is required for Tfh cell expansion and IFN-γ production and viral-specific GC output. Activated STAT4 promotes T-bet expression, as in Th1 cells ([@bib55]; [@bib63]), along with IL-21. STAT4 and T-bet expression is driven by IL-12 and IFN-β. Both are needed to transcriptionally regulate Tfh cell expansion and coproduction of IL-21 and IFN-γ and, along with Bcl6, enable a proper GC response upon type 1 immune response. The loss of T-bet expression in Tfh cells during a chronic infection, such as experimental malaria ([@bib8]), accordingly leads to the loss of IFN-γ production, but not of IL-21. This imbalance results in improper GC B cell class switching from IgG2c to IgG1 and the failure of pathogen clearance. Conversely, our findings potentially explain the persistence of GCs and production of pathogenic IgG2a autoantibodies in chronic autoimmune diseases, such as systemic lupus erythematosus, which are driven by aberrant production of IL-12 and type I IFNs ([@bib44]; [@bib30]; [@bib22]), with downstream STAT4- and T-bet--mediated transcriptional activation in Tfh cells.

Materials and methods {#s10}
=====================

Mice {#s11}
----

Mice were housed in pathogen-free conditions at the Yale School of Medicine, New Haven, CT. C57BL/6J (B6), B6.*Tcra^tm1Mom^*, B6.129S6-*Tbx21^tm1Glm^*/J, and C.129S2-*Stat4^tm1Gru^*/J animals were purchased from the Jackson Laboratory. B6.Tg(TcrLCMV)1Aox (SMARTA; Stg) mice ([@bib64]) were provided by S. Kaech (Yale University, New Haven, CT). All animals were used at 6--8 wk of age, with approval for procedures given by the Institutional Animal Care and Use Committee of Yale University.

Cell transfers and viral infections {#s12}
-----------------------------------

2.5 × 10^4^ naive Stg TCR transgenic CD4 T cells were transferred to recipient mice via retroorbital injection. Mice were infected i.p. with 2 × 10^5^ PFU LCMV Armstrong 24 h after transfer. Animals were sacrificed at different time points p.i., and harvested spleens were processed for flow cytometry.

ELISA for antibodies to LCMV {#s13}
----------------------------

Anti-LCMV antibodies were measured by ELISA using sonicated cell lysate from LCMV-infected BHK-21 cells as capture Ag. 96-well microtiter plates (Polysorp; Nunc) were coated overnight with lysate in PBS. The antibodies used are listed in Table S1. ODs were read at 405 nm (Softmax Pro 3.1 software; Molecular Devices).

Flow cytometry and cell sorting {#s14}
-------------------------------

Tissues were homogenized by crushing with the head of a 1-ml syringe in a Petri dish followed by straining through a 40-µm nylon filter. Ammonium--chloride--potassium buffer was used for red blood cell lysis, and remaining cells were counted. Antibodies used for flow cytometry staining are listed in Table S1. Staining for CXCR5 was performed at room temperature (25°C) with 30 min of incubation. Intracellular staining for cytokines was performed using Cytofix/Cytoperm kits (BD Biosciences) according to the manufacturer's protocol. Stained and rinsed cells were analyzed using a multilaser cytometer (LSRII; BD Biosciences). We performed a CD40L surface mobilization as previously described ([@bib31]). In brief, cells were blocked with anti--Fc-γRII/III antibody, and 10 µg/ml APC-labeled anti-CD40L was introduced into the cell culture immediately before stimulation with 50 ng/ml PMA and 1 µg/ml ionomycin (Sigma-Aldrich), followed by 30-min incubation at 37°C. After three washes, cells were surface stained to identify subsets of CD4^+^ T cells. For sorting, CD4^+^ T cells were enriched using a biotin-based magnetic separation kit (EasySep; StemCell Technologies) before cell surface staining, with specific populations sorted using a cell sorter (FACSAria; BD Biosciences).

Microscopy {#s15}
----------

Spleens were snap frozen in optimum cutting temperature tissue-freezing solution and stored at −80°C. Tissues were cut into 8-µm sections and processed as described previously ([@bib61]). Reagents used to stain sections are listed in Table S1. Images were obtained from a laser-scanning confocal microscope (510 META; Carl Zeiss) at 25× magnification. ImageJ software (National Institutes of Health) was used for the measurement of GC and B cell follicle size, distance measurements, and for T cell counting. The latter analyses were performed in a blinded manner.

Transwell migration assays {#s16}
--------------------------

Chemotaxis assays were performed as described previously ([@bib5]). 5 × 10^5^ enriched CD4^+^ splenic T cells were incubated for 1 h with 1× DMEM containing 0.5% fatty acid--free BSA (EMD Biosciences), 5% antibiotics, [l-]{.smallcaps}glutamine (Cellgro), and Hepes. Cells were then allowed to migrate through 5-µm-pore--sized transwells (Corning) toward soluble CXLC13 (R&D Systems) or media alone for 3 h at 37°C. Cells were collected, stained, and resuspended in 45 µl of staining buffer and analyzed by flow cytometry.

Retroviral transduction {#s17}
-----------------------

Transductions were done as previously described ([@bib70]). In brief, 1 mg LMP and T-bet shRNA vectors with 0.5 mg EcoHelp plasmid was used to transfect HEK293T viral packaging cells using X-tremeGENE 9 DNA transfection reagent (Roche) overnight. The media were then replaced, and viruses were grown for another 24 h. 6 × 10^6^ splenocytes were activated for 24 h using CD3 plus CD28 stimulation and spin transduced with the supernatant of the transfection with polybrene. After transduction, 5 × 10^5^ T cells were transferred via retroorbital injection into infected B6 recipients that were subsequently infected with LCMV Armstrong or *Nippostrongylus brasiliensis* plus OVA administration ([@bib90]).

Quantitative PCR {#s18}
----------------

Real-time PCR was set up using Brilliant II SYBR Green Master Mix and performed on an thermal cycler (MX4005P) according to the manufacturer's protocols (Agilent Technologies), using the primers as noted in Table S2. Expression was calculated with the ΔΔxp method normalized to *Hprt*, and all measurements were performed in triplicate.

RNA-seq and analysis {#s19}
--------------------

Tfh cell populations were sorted by flow cytometry, with two separate sorts performed on different days, pooling spleens of 10 mice each day. Quality verification, library preparation, and sequencing were performed at the Yale Center for Genomic Analysis. Samples were sequenced on a high-throughput sequencing system (HiSeq 2500; Illumina) using 75-bp paired-end reads. RNA-seq was performed using Partek Flow (Partek Inc.). Reads were aligned to the mm9 mouse genome using STAR version 2.41d; unaligned reads were then aligned using TopHat version 2.1.0, and differential expression of the combined reads was then computed with Quantify to the annotation model (Partek E/M). Differentially expressed genes were filtered by keeping transcripts with at least one read from each population significant at the FDR-adjusted p-value of \<0.05 between two of the populations, and fragments per kilobase of transcript per million mapped reads were summed across isoforms to obtain data for 668 significant genes. Clustering was done using hierarchical clustering in Partek by the average method or the partitioning around medoids method and Euclidean distance metrics. For heat maps, expression values were normalized per gene. Pathway enrichment analysis was performed using MetaCore (version 6.31 build). Enrichment analysis was performed using GSEA software v3.0 (Broad Institute), with the following settings: 1,000 gene set permutations, data collapsed to gene symbols using max probe mode, enrichment statistic = weighted, and ranking metric = Log2ratio of classes.

ATAC-seq {#s20}
--------

Sorted cells were lysed in buffer (10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl~2~, and 0.1% octylphenoxypolyethoxyethanol for 15 min at 4°C and then centrifuged and resuspended with transposase reaction mix (2× tagmented DNA buffer, transposase \[Ilumina Nextera\], and nuclease-free water) and incubated for 30 min at 37°C. Cells were then added to a MinElute column (Qiagen) and PCR amplified in KAPA HiFi 2× mix (Kapa Biosystems) with barcoding primers ([@bib6]). Amplification was conducted for 45 s at 98°C, followed by five cycles of denaturing at 98°C for 15 s, annealing at 63°C for 30 s, extension at 72°C for 30 s, and a final extension of 72°C for 1 min in a thermal cycler (MX4005P). PCR products were cleaned with MinElute columns, and size exclusion was performed with magJet NGS Cleanup and Size Selection kit (Thermo Fisher). Quantitative PCR library amplification test and PCR library amplification were performed as previously described ([@bib7]). DNA processing and high-throughput sequencing were performed as described in the previous section. Sequenced reads were mapped to the mouse genome (mm10 NCBI Build 38) using the Burrows-Wheeler Aligner version 0.7.9a alignment program. Reads mapping to the ENCODE project blacklist of repetitive regions and mitochondrial regions were removed ([@bib16]). MACS2 program version 2.1.0.20150420 was used to identify peaks using parameters nomodel shift −100 extsize 200 with a q value of \<0.05. Read counts for open chromatin regions in all samples were obtained using the DiffBind version 2.0.7 package ([@bib72]) with DESEQ2 normalization using read counts in analyzed regions (parameter bFullLibrarySize = FALSE). Statistically significant differentially accessible regions were identified by DiffBind using the DESEQ2 method with default parameters. Peaks were annotated to mouse genome sequence features using the annotatePeak function in the Chipseeker version 1.8.9 package ([@bib92]) and the University of California, Santa Cruz, mm10 knownGene database using parameter tss Region from −1,000 to +1,000 bp relative to the transcription start site.

Statistics {#s21}
----------

Data were analyzed using the Student's *t* test or Fisher's exact test with Prism 6 (GraphPad Software). The number of asterisks represents the degree of significance with respect to p-value, with the exact value presented within each figure legend.

Deposition of data {#s22}
------------------

RNA sequencing and ATAC-seq data have been deposited into the GEO database (accession nos. [GSE105806](GSE105806), [GSE105807](GSE105807), and [GSE105808](GSE105808)).

Online supplemental material {#s23}
----------------------------

Fig. S1 shows that endogenous Tfh cells express T-bet and coproduce IFN-γ and IL-21. Fig. S2 demonstrates that T-bet is not required for Tfh cell differentiation in type 2 infection. Fig. S3 demonstrates that T-bet expression in Tfh cells is necessary for proper GC development. Fig. S4 shows pSTAT4 in Tfh cells during viral infection. Fig. S5 reveals that STAT4 is required for cytokine production by Tfh cells, but not their development. Table S1 lists the antibodies used for flow cytometry, ELISA, and microscopy. Table S2 lists the primer sets used for quantitative PCR. Table S3 shows statistically significant differentially accessible regions from ATAC-seq.
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